CEO John Maslowski of Fibrocell Science Inc. (NASDAQ: FCSC), joins Uptick Newswire to discuss fighting diseases with cell and gene therapies for localized treatment.

NASDAQ: FCSC # Biotechnology # autologous cell and gene therapies # personalized biologic # focus on the patient # Arthritis and Related Conditions # FCX-007 # FCX-013 # fibroblasts # Gene Therapy Research Program # Localized Scleroderma # Recessive Dystrophic Epidermolysis Bullosa